Pediatric inflammatory bowel disease and depression: treatment implications

Area of Science:

• Pediatric Gastroenterology
• Child Psychiatry
• Behavioral Medicine

Background:

• Depression is a common and heterogeneous condition in pediatric inflammatory bowel disease (IBD).
• Integrating behavioral health into IBD care is recognized as beneficial, but targeted psychiatric treatments require systematic exploration.
• Diverse predisposing and precipitating factors contribute to depression in this population.

Purpose of the Study:

• To review neurobiological and psychosocial risk factors for depression in pediatric inflammatory bowel disease.
• To explore how these factors influence treatment decisions for depression in IBD.
• To discuss empirically supported interventions within this context.

Main Methods:

• Systematic review of literature on depression in pediatric inflammatory bowel disease.
• Analysis of neurobiological factors (inflammation, corticosteroids, pain, sleep).
• Analysis of psychosocial factors (illness perception, stressors, coping).

Main Results:

• Neurobiological factors include inflammation, corticosteroid treatment, pain, and sleep disturbance.
• Psychosocial factors encompass illness perception, reactions to illness, and environmental stressors.
• Both psychosocial and psychopharmacological interventions are discussed in relation to these factors.

Conclusions:

• Recognizing diverse pathways to depression in pediatric IBD is crucial for developing targeted interventions.
• Improved integration of psychosocial care into medical management of IBD can enhance patient outcomes.
• Tailored treatments addressing specific neurobiological and psychosocial aspects of depression are needed for youths with IBD.